$2.39
0.09[3.91%]
At close: Apr 26
$2.39
0[0.00%]
After Hours: 4:00PM EDT
Taysha Gene Therapies
(NASDAQ:TSHA)Taysha Gene Therapies Stock (NASDAQ:TSHA), Insider Trading Activity
Taysha Gene Therapies: Insider buying and selling updated today.
Shares Outstanding
187.018M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2023 | Paul Manning | 10% OWNER | 100K | $1.63 | $163.00K | BUY | 0.47% | 21.404074M | Nov 17 | View |
| Aug 25, 2023 | Kamran Alam | CHIEF FINANCIAL OFFICER | -33K | $2.33 | -$76.89K | SELL | -11.34% | 258.042K | Aug 24 | View |
| Aug 16, 2023 | Paul Manning | 10% OWNER | 16.466667M | $0.90 | $14.82M | BUY | 340.40% | 21.304074M | Aug 16 | View |
| Aug 16, 2023 | John Stalfort III | DIRECTOR | 827.778K | $0.90 | $700.00K | BUY | 373.54% | 1.049381M | Aug 16 | View |
| Aug 16, 2023 | Sean Nolan | CHIEF EXECUTIVE OFFICER | 444.444K | $0.90 | $400.00K | BUY | 40.69% | 1.536715M | Aug 16 | View |
| Aug 16, 2023 | Phillip Donenberg | DIRECTOR | 111.111K | $0.90 | $100.00K | BUY | 3703.70% | 114.111K | Aug 16 | View |
| Jul 14, 2023 | R.A. Session II | -85.872K | $0.71 | -$60.77K | SELL | -0.94% | 9.012837M | Jul 12 - Jul 13 | View | |
| Jun 26, 2023 | R.A. Session II | 10% OWNER | -28.608K | $0.70 | -$20.12K | SELL | -0.31% | 9.098709M | Jun 22 - Jun 23 | View |
| Jun 22, 2023 | R.A. Session II | 10% OWNER | -434.615K | $0.71 | -$307.84K | SELL | -4.55% | 9.127317M | Jun 20 - Jun 21 | View |
| May 18, 2023 | Sukumar Nagendran | PRESIDENT AND HEAD R&D | 5K | $0.68 | $3.40K | BUY | 17.11% | 34.226K | May 16 | View |
| Nov 02, 2022 | Paul Manning | DIRECTOR | 1.5M | $2.00 | $3.00M | BUY | 44.95% | 4.837407M | Oct 31 | View |
| Aug 24, 2022 | Kamran Alam | CHIEF FINANCIAL OFFICER | -3.325K | $3.47 | -$11.54K | SELL | -1.23% | 266.121K | Aug 23 | View |
| Aug 22, 2022 | Kamran Alam | CHIEF FINANCIAL OFFICER | -28.675K | $3.70 | -$106.00K | SELL | -9.62% | 269.446K | Aug 18 - Aug 22 | View |
| Jul 07, 2022 | SUYASH PRASAD | CMO AND HEAD R&D | -12.861K | $3.70 | -$47.65K | SELL | -2.37% | 530.589K | Jul 05 - Jul 06 | View |
| Jul 01, 2022 | SUYASH PRASAD | CMO AND HEAD R&D | -50.139K | $3.65 | -$183.08K | SELL | -8.45% | 543.45K | Jun 29 - Jul 01 | View |
| Feb 04, 2022 | Paul Manning | DIRECTOR | 201.602K | $7.80 | $1.57M | BUY | 3.96% | 5.286909M | Feb 02 - Feb 03 | View |
| Feb 03, 2022 | Sukumar Nagendran | DIRECTOR | 10K | $8.01 | $80.10K | BUY | 52.01% | 29.226K | Feb 02 | View |
| Feb 03, 2022 | Phillip Donenberg | DIRECTOR | 3K | $7.78 | $23.34K | BUY | ∞ | 3K | Feb 02 | View |
| Dec 08, 2021 | RA Session II | PRESIDENT AND CEO | 42.518K | $12.44 | $529.10K | BUY | 0.46% | 9.33201M | Nov 23 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.